Rituxan (rituximab) - Roche
Pancytopenia and isolated cytopenias as hematological complications of SLE: A narrative review. (PubMed, Adv Clin Exp Med) - Sep 15, 2026 - "The role of rituximab (RTX) in the management of pancytopenia and isolated cytopenias associated with SLE is discussed in detail...Early recognition of pancytopenia remains a clinical challenge and requires well-structured diagnostic and therapeutic strategies. A thorough understanding of its underlying mechanisms and clinical manifestations is essential to avoid delays in treatment and prevent complications." 
Journal • Review • Aplastic Anemia • Complement-mediated Rare Disorders • Hematological Disorders • Hemophagocytic lymphohistiocytosis • Immunology • Inflammatory Arthritis • Leukopenia • Lupus • Myelofibrosis • Paroxysmal Nocturnal Hemoglobinuria • Rare Diseases • Systemic Lupus Erythematosus • Thrombocytopenia
http://www.ncbi.nlm.nih.gov/pubmed/42735432
 
Kacper Siemek; Katarzyna Wojakowicz; Magdalena Szmyrka; Oliwia Kubi?; Zuzanna Rzepkowska
 
Sep 15, 2026
 
Prev Next